MARK3 Activators
MARK3 activators belong to a distinct chemical class characterized by their ability to modulate the activity of the MARK3 kinase enzyme. MARK3, or Microtubule Affinity-Regulating Kinase 3, is a member of the AMP-activated protein kinase (AMPK) family and plays a crucial role in various cellular processes, particularly those involved in cytoskeletal dynamics and cell polarity. The activation of MARK3 is intricately linked to its regulatory function in phosphorylating microtubule-associated proteins, thereby influencing microtubule stability and cellular architecture.
Chemically, MARK3 activators are designed to interact with the catalytic domain of the MARK3 kinase, inducing a conformational change that leads to increased enzymatic activity. This class of compounds often comprises small molecules with specific structural motifs that facilitate their binding to the kinase domain, promoting either an allosteric activation or preventing inhibitory interactions. The intricate interplay between MARK3 activators and the kinase's regulatory mechanisms underscores their potential to fine-tune cellular processes reliant on microtubule dynamics. Research in this field aims to elucidate the precise mechanisms through which MARK3 activators exert their influence on cellular functions, shedding light on the broader implications for cell biology and potentially paving the way for the development of novel tools for research and discovery in the realm of cellular signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A is a calcineurin inhibitor that blocks the activity of the phosphatase calcineurin. This leads to reduced dephosphorylation of NFAT, a transcription factor that is critical for the expression of IL-2. In turn, the inhibition of IL-2 expression diminishes T-cell activation, which indirectly enhances the activity of MARK3 by reducing competition for ATP and other co-factors. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I is a potent and selective inhibitor of protein kinase C (PKC). By inhibiting PKC, it prevents the phosphorylation and activation of downstream targets of PKC. This can indirectly enhance the activity of MARK3, as PKC is often a competing kinase for phosphorylation substrates and co-factors. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases, including PKC and PKA. By inhibiting these kinases, it can indirectly enhance the activity of MARK3. Both PKC and PKA are competitors of MARK3 for phosphorylation substrates. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a potent inhibitor of ROCK (Rho-associated protein kinase). By inhibiting ROCK, it can increase the availability of substrates and ATP for other kinases such as MARK3, thereby indirectly enhancing its activity. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H89 is a potent inhibitor of protein kinase A (PKA). By inhibiting PKA, H89 increases the availability of substrates and ATP for other kinases, including MARK3, which can indirectly enhance its activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a potent inhibitor of JNK. By inhibiting JNK, it increases the availability of substrates and ATP for other kinases, such as MARK3, thereby indirectly enhancing its activity. | ||||||
KN-62 | 127191-97-3 | sc-3560 | 1 mg | $136.00 | 20 | |
KN-62 is a potent and selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). By inhibiting CaMKII, it can indirectly enhance the activity of MARK3 by reducing competition for phosphorylation substrates and ATP. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of phosphoinositide 3-kinases (PI3K). By inhibiting PI3K, it can indirectly enhance the activity of MARK3 by reducing competition for ATP and other co-factors. | ||||||